HERBAL APPROACHES TO HYPERLIPIDEMIA. Patrick M. Fratellone, MD, RH (AHG), FIM, FACC New York, New York
|
|
- Benjamin Howard
- 5 years ago
- Views:
Transcription
1 HERBAL APPROACHES TO HYPERLIPIDEMIA Patrick M. Fratellone, MD, RH (AHG), FIM, FACC New York, New York Patrick M. Fratellone, MD, RH (AHG) FIM, FACC November, 2013
2 CASE PRESENTATIONS
3 CASE #1 46 YEAR OLD WHITE MALE WITH A HISTORY OF HTN AND HYPERLIPIDEMIA. PREVIOUS MEDICATIONS INCLUDED: PREVIOUS MEDICATIONS: 1. Avapro 300 mg PO qd BP: 160/92 2. Diovan 80/12.5 mg PO bid BP: 140/90 Labs: Cholesterol 238 ; TG 140; LDL 160; HDL 50 Trial of Benecar 20mg PO qd started: BP measurements: / / /78 Add diuretic: Benecar 20/12.5 qd; BP / 60-70
4 CASE #2 53 YEAR OLD WHITE MALE PRESENTS WITH A PAST MEDICAL HISTORY OF 2 MI, 2 STENTS OF THE RCA IN 1998 AND 1999 AND A THIRD STENT IN Current medications: 1. Toprol XL: 100 mg PO qd 4. ASA 81mg PO qd 2. Diovan/Hct 80/12.5 mg PO qd 5. Imdur 30 mg PO qd 3. Plavix 75mg PO qd 6. Lipitor 20mg PO qd BP 140/80-90; Labs: Cholesterol 137; TG 210; HDL 32 ; LDL 63 CRP-HS 4.1; Fibrinogen 334; Homocysteine 8.55; microalbumin 4.0 (NL < 2.9 ) Results: Mycoplasma fermentans Treatment Plan: Benecar 20/12.5 mg PO qd Retest microalbumin in 6 weeks
5 CASE #3 73 YEAR OLD BLACK FEMALE WITH A PAST MEDICAL HISTORY OF HTN X 20YEARS. BP RANGES FROM 130/90 TO 200/120. SHE HAS DYSPNEA ON EXERTION. DENIES CHEST PAIN, AND SYNCOPE; HAS NEW EDEMA PRESENT AND PALPITATIONS Current Medication: Labs: 1. Calan SR 180 mg PO qd x 15 years BP: 160 / Hyzaar 100/25 mg PO qd Cholesterol 140; TG 91; HDL 61; LDL 68; Homocysteine 12.1; 18; CRP HS 4.6 ; Labs: microalbumin: 6.0 ; Microalb/creat ratio:.050 (NL <.020) Plan: 1. Stress thallium: NL 2. Holter : NSR with PAF 3. Change Calan to Tiazac 180mg PO qd 4. Change Hyzaar to Benecar 20/12.5 qd 5. BP on new regimen: 140/90
6 CASE #4 60 YEAR OLD WHITE MALE WITH A HISTORY OF HYPERTENSION, CAD, HYPERLIPIDEMIA,AND DEPRESSION ; PATIENT REFUSED INVASIVE PROCEDURE AFTER ABNORMAL STRESS TEST. PATIENT ELECTED TO HAVE EECP. POST STRESS EECP: NO ISCHEMIA PRESENT Medications: 1. Nadolol 80 mg PO qd 3. Welchol 625mg PO -6/day 2. Norvasc 2.5 mg PO qd 4. ASA 81 mg PO qd Vitals: 140/ 90 -HR 55- Weight 231 Labs: microalbumin/creat =.040 ( NL <.020 ) Cholesterol 214; LDL 139; TG 112; HDL 53 Treatment Plan: 1. Discontinue welchol change to lipitor 20 mg PO qd 2. Discontinue Norvasc as edema; start micardis/hct 80/12.5 mg PO qd 3. BP no change 140 / 90 after 1 month 4. Discontinue micardis; start : Benecar HCt 40/12.5 mg PO qd 5. BP 130/80 after 1 month
7 HERBAL APPROACHES TO HYPERLIPIDEMIA Total Cholesterol <200 Triglycerides <150 HDL High Density Lipoprotein LDL Male >40 Female > 50 Low Density Lipoprotein 1. < < <70
8 CHOLESTEROL Made in the liver Parent molecule for other hormones Statins: Inhibit HMG co-reductase
9 LIPID PARTICLES Confirm type of particle size both HDL and LDL This is done by Berkley Heart Lab and other labs Quest Lab: VAP, NMR Bioreference: ACT
10 TWO TYPES OF HDL (GOOD CHOLESTEROL) Good, with a good particle Good particles are large, fluffy (buoyant) Protection for the heart HDL-II Good, with a bad particle Bad particles are small, dense Non-protection for the heart HDL III
11 TWO TYPES OF LHDL (BAD CHOLESTEROL) Bad, with a good particle Good particles are large, fluffy Not associated with heart disease This is Pattern A Bad, with a Bad particle Good particles are large, fluffy Associated with heart disease This is Pattern B
12 TREATMENT Before treatment Determine particle size of both HDL and LDL More important to treat LDL with bad particles Treatment Dietary lifestyle changes Less meat,, dairy, and inflammatory foods decrease LDL High alkaline foods Decrease in refined carbohydrates increase HDL Increase in Omega 3 (Cold water fish) Exercise lifestyle changes Increase HDL (Good cholesterol)
13 TREATMENT (CONTINUED) Statin Drugs Conventional treatment Supporting evidence of benefits Side effects Liver Muscle Depression Memory Loss Sexual Drive Deplete Coenzyme Q10 Levels
14 TREATMENT (CONTINUED) Herbal Treatment Red Rice Yeast (Monecus purpurus) Green Tea (Camellia sinensis) Garlic (Allium sativum) B Sitosterol (Plant sterols)
15 RED RICE YEAST (MONECUS PURPURUS)
16 GREEN TEA (CAMELLIA SINENSIS)
17 GARLIC (ALLIUM SATIVUM)
18 B SITOSTEROL (PLANT STEROLS)
19 CASE 1 43 year old white male with a family history of cardiovascular disease presents to your office. He is anxious as his father had his first heart attack at age 43. He has had a corporate physical revealing a blood pressure of 126/74, heart rate 72, height 5 8, weight 198. He has no complaints. Physical examination: Unremarkable Takes no medications DISCUSSION: 1. What else would you like to know about this patient? 2. What blood tests would you like to see? 3. Do you need an electrocardiogram?
20 CASE 1 1. ECG: Normal 2. LABS: Chemistry normal: fasting glucose LIPIDS: 1. Total cholesterol HDL TG LDL 120
21 CASE 2 72 year old post menopausal female with a known history of heart disease wants a different approach to her health. She feels she takes too many medications. Her medications include: Cozaar (ARB) 100mg PO qd Lipitor (statin) 40 mg PO qd HCTZ (diuretic) 25 mg PO qd Actonel does not recall dose Metformin 500 mg PO b.i.d. Namendia 10 mg PO qd Aricept 5 mg PO q.d. Vitals: 130/72 HR: 74 Height 5 6 Weight: 147 Physical Exam: Mildly obese; Systolic murmur 2/6 Apex and Axilla OTHERWISE NORMAL EXAM
22 CASE 2 1. Cholesterol LDL HDL TG FBS Potassium NL CBC Otherwise other labs normal DISCUSSION:
23 CASE 3 64 year old male with a history of hyperlipidemia on medications. Patients wants to stop his statin drug. He feels this is a family-type of cholesterol trait. He exercises regularly. His diet is clearly not his problem. Medications: Crestor 5.0 mg PO qd Labs: Cholesterol 170 TG: 84 LDL: 110 HDL: 46 DISCUSSION: 1. Would you stop the statin as he asks? 2. What blood tests would help you make your decision?
24 SUPPLEMENTS 1. Vitamin E 2. B Vitamins 3. Carotenoids 4. Flavonoids 5. Magnesium 6. Coenzyme Q10 7. L-Carnitine 8. Omega 3 Fatty Acids 9. L-Arginine 10. L-Taurine
25 IT S BEEN A PLEASURE THANK YOU!
Hypertension, Hyperlipidemia and Obesity. Mi-CCSI
Hypertension, Hyperlipidemia and Obesity Mi-CCSI Objectives Review the prevalence of hypertension, hyperlipidemia and obesity Correlation of the 3 conditions Discuss why it is important to treat these
More informationMi-CCSI welcomes you to the 2 nd in our 4 part Basics of Disease Management Webinar Series
Our speaker today is: Susan Vos, BSN, RN, CCM Mi-CCSI welcomes you to the 2 nd in our 4 part Basics of Disease Management Webinar Series We will be starting shortly A few housekeeping items: We will be
More informationUnderstanding Cholesterol Holistically
Understanding Cholesterol Holistically Dr. Molly Force & Dr. Alicia McCubbins 213 Decatur Street, Port Townsend www.prospernaturalhealth.com (360)385-5375 This presentation is meant for educational use
More informationScreening Results. Juniata College. Juniata College. Screening Results. October 11, October 12, 2016
Juniata College Screening Results Juniata College Screening Results October 11, 2016 & October 12, 2016 JUNIATA COLLEGE The J.C. Blair Hospital CARES team screened 55 Juniata College employees on October
More informationCardioGenomicPlus Profile
CardioGenomicPlus Profile Patient: SAMPLE PATIENT DOB: Sex: MRN: Apo E Chromosome 19 APOE APO E2: cys / cys APO E3: cys / arg APO E4: arg / arg The two SNPs lead to 3 possible variants for each chromosome,
More informationComprehensive Treatment for Dyslipidemias. Eric L. Pacini, MD Oregon Cardiology 2012 Cardiovascular Symposium
Comprehensive Treatment for Dyslipidemias Eric L. Pacini, MD Oregon Cardiology 2012 Cardiovascular Symposium Primary Prevention 41 y/o healthy male No Medications Normal BP, Glucose and BMI Social History:
More informationDiabetes: Use of Adjunctive Therapy ACEs, ARBs, ASA & STATINs --Oh My! Veronica J. Brady, PhD, FNP-BC, BC-ADM, CDE Project ECHO April 19, 2018
Diabetes: Use of Adjunctive Therapy ACEs, ARBs, ASA & STATINs --Oh My! Veronica J. Brady, PhD, FNP-BC, BC-ADM, CDE Project ECHO April 19, 2018 Points to Ponder ASCVD is the leading cause of morbidity
More informationDaiichi Sankyo, Inc. (DSI)
Daiichi Sankyo, Inc. (DSI) Outlook for U.S. Business for 2009 Nov. 7 th, 2007 Joseph P. Pieroni President and CEO Daiichi Sankyo, Inc. Largest Pharmaceutical markets $300 $274.4 Annual Sales (US$ billions)
More informationPolish Your Practice Heart Failure. Why Prevent Vs. Treat? Coronary Heart Disease. A Challenging Patient:1994. Risk Factors for Heart Attack
Polish Your Practice Heart Failure Lipid Management for the Prevention of Coronary Heart Disease in 2008 Carl E. Orringer, MD, FACC Clinical Associate Professor of Medicine Case Western Reserve University
More informationCase Presentation. Moderator: Sharon Liu, DO Associate Internal Medicine Chief Austin Regional Clinic Austin, Texas
Case Presentation Moderator: Sharon Liu, DO Associate Internal Medicine Chief Austin Regional Clinic Austin, Texas Izzy (2006) 51 y/o Hispanic woman with a history of diabetes and obesity. Her diabetes
More informationJoshua Shepherd PA-C, MMS, MT (ASCP)
Joshua Shepherd PA-C, MMS, MT (ASCP) None What is Cholesterol? Why cholesterol is it important? Review the National Cholesterol Education Programs guidelines (NCEP-ATPIII) Discuss New guidelines from the
More informationCHOLESTEROL REDUCING MEDICATIONS. Five Main Categories. 1. Statins 2. Fibrates 3. Resins 4. Niacin 5. Cholesterol absorption inhibitor
Page 1 of 5 PHA-GEN-002-2004 CHOLESTEROL REDUCING MEDICATIONS Five Main Categories 1. Statins 2. Fibrates 3. Resins 4. Niacin 5. Cholesterol absorption inhibitor Statins Also called HMG-CoA reductase inhibitors
More informationLiving a Heart Healthy Life. Eleanor Stewart, MSN, RN, AGACNP-BC
Living a Heart Healthy Life Eleanor Stewart, MSN, RN, AGACNP-BC What are YOU grateful for? So. What exactly is heart disease anyway? MI Atrial fibrillation Heart attack CAD murmur High bad cholesterol
More informationBIOCHEMISTRY BLOOD - SERUM Result Range Units
BIOCHEMISTRY BLOOD - SERUM Result Range Units LIPIDS CHOLESTEROL 3.9 0.0-5.5 mmol/l TRIGLYCERIDES 0.7 < 1.5 mmol/l LIPID STUDIES HDL(Protective) 1.5 > 1.2 mmol/l LDL(Atherogenic) 2.1 0.5-3.5 mmol/l Cholesterol/HDL
More informationA 45 year old African American man presents to the IMC with a chief complaint of my
AN EVIDENCE BASED APPROACH TO HYPERTENSION AND HYPERLIPIDENIA: A CASE STUDY A 45 year old African American man presents to the IMC with a chief complaint of my pressure is high. Apparently he recently
More informationSession 21: Heart Health
Session 21: Heart Health Heart disease and stroke are the leading causes of death in the world for both men and women. People with pre-diabetes, diabetes, and/or the metabolic syndrome are at higher risk
More information9/13/2017. Presented by UIC College of Nursing Jessy Thomas FNP, MSN, MPH. Introduction Background Management
Presented by UIC College of Nursing Jessy Thomas FNP, MSN, MPH Introduction Background Management 2 1. Provide a basic level of knowledge regarding hypertension and hyperlipidemia to care coordinators/
More informationThese critical heart disease tests your doctor is ignoring could SAVE YOUR LIFE!
These critical heart disease tests your doctor is ignoring could SAVE YOUR LIFE! I m only in my fifties and my arteries are already all plugged up. I even had to agree to have stents put in! I just don
More informationConflict of Interest Disclosure. Learning Objectives. Learning Objectives. Guidelines. Update on Lifestyle Guidelines
Conflict of Interest Disclosure Updates for the Ambulatory Care Pharmacist: Dyslipidemia and CV Risk Assessment No conflicts of interest to disclose 2014 Updates to the Updates in Ambulatory Care Pharmacy
More informationHypertension and Hyperlipidemia. University of Illinois at Chicago College of Nursing
Hypertension and Hyperlipidemia University of Illinois at Chicago College of Nursing 1 Learning Objectives 1. Provide a basic level of knowledge regarding hypertension and hyperlipidemia and care coordinators/
More informationMaintain Cholesterol
Maintain Cholesterol What is Cholesterol? Cholesterol is a Lipid Molecule that has a waxy appearance and is found in every cell of the body and has some important natural functions. It is manufactured
More informationThe New Gold Standard for Lipoprotein Analysis. Advanced Testing for Cardiovascular Risk
The New Gold Standard for Lipoprotein Analysis Advanced Testing for Cardiovascular Risk Evolution of Lipoprotein Testing The Lipid Panel Total Cholesterol = VLDL + LDL + HDL Evolution of Lipoprotein Testing
More informationLipoprotein Particle Profile
Lipoprotein Particle Profile 50% of people at risk for HEART DISEASE are not identified by routine testing. Why is LPP Testing The Most Comprehensive Risk Assessment? u Provides much more accurate cardiovascular
More informationSPECIAL REPORT.
SPECIAL REPORT www.markstengler.com All rights reserved. This program, or parts thereof, may not be reproduced in any form without permission in writing from the author. Copyright 2017 by Mark Stengler
More informationObjectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015
Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015 Presentation downloaded from http://ce.unthsc.edu Objectives Understand that the obesity epidemic is also affecting children and adolescents
More informationCase Discussions: Treatment Strategies for High Risk Populations. Most Common Reasons for Referral to the Baylor Lipid Clinic
Case Discussions: Treatment Strategies for High Risk Populations Peter H. Jones MD, FNLA Associate Professor Methodist DeBakey Heart and Vascular Center Baylor College of Medicine Most Common Reasons for
More informationB. Patient has not reached the percentage reduction goal with statin therapy
Managing Cardiovascular Risk: The Importance of Lowering LDL Cholesterol and Reaching Treatment Goals for LDL Cholesterol The Role of the Pharmacist Learning Objectives 1. Review the role of lipid levels
More informationDr. Jonathan Spages D.C.
17 Natural Ways to Lower Cholesterol Dr. Jonathan Spages D.C. Copyright 2017 All Rights Reserved No part of this book may be reproduced in any form or by any electronic or mechanical means including information
More information!!! Aggregate Report Fasting Biometric Screening CLIENT!XXXX. May 2, ,000 participants
Aggregate Report Fasting Biometric Screening CLIENTXXXX May 2, 2014 21,000 participants Contact:404.636.9437~Website:www.atlantahealthsys.com RISK FACTOR QUESTIONNAIRE Participants Percent Do not exercise
More informationOM s Health Corner Cholesterol & Heart Disease!!
Cholesterol & Heart Disease!! We may associate cholesterol with fatty foods, but most of the waxy substance is made by our own bodies. The liver produces 75% of the cholesterol that circulates in our blood.
More informationKEY COMPONENTS. Metabolic Risk Cardiovascular Risk Vascular Inflammation Markers
CardioMetabolic Risk Poor blood sugar regulation and unhealthy triglyceride and lipoprotein levels often present long before the diagnosis of type 2 Diabetes. SpectraCell s CardioMetabolic and Pre-Diabetes
More informationAdams Memorial Hospital Decatur, Indiana EXPLANATION OF LABORATORY TESTS
Adams Memorial Hospital Decatur, Indiana EXPLANATION OF LABORATORY TESTS Your health is important to us! The test descriptions listed below are for educational purposes only. Laboratory test interpretation
More informationCVD Prevention, Who to Consider
Continuing Professional Development 3rd annual McGill CME Cruise September 20 27, 2015 CVD Prevention, Who to Consider Dr. Guy Tremblay Excellence in Health Care and Lifelong Learning Global CV risk assessment..
More informationDifficult to Treat Hypertension
Difficult to Treat Hypertension According to Goldilocks JNC 8 Blood Pressure Goals (2014) BP Goal 60 years old and greater*- systolic < 150 and diastolic < 90. (Grade A)** BP Goal 18-59 years old* diastolic
More informationCARDIAC IMAGING QUESTIONNAIRE
Date of test: / / Month day year Last name First name Middle initial Street address City State Zip code Home phone ( ) - Work phone ( ) - Cell Phone ( ) - Email: Age: Demographics: What is your ethnicity?
More informationHigh Blood Cholesterol What you need to know
National Cholesterol Education Program High Blood Cholesterol What you need to know Why Is Cholesterol Important? Your blood cholesterol level has a lot to do with your chances of getting heart disease.
More informationAmerican Diabetes Association: Standards of Medical Care in Diabetes 2015
American Diabetes Association: Standards of Medical Care in Diabetes 2015 Synopsis of ADA standards relevant to the 11 th Scope of Work under Task B.2 ASSESSMENT OF GLYCEMIC CONTROL Recommendations: Perform
More informationHow Low Do We Go? Update on Hypertension
How Low Do We Go? Update on Beth L. Abramson, MD, FRCPC, FACC As presented at the University of Toronto s Saturday at the University Session (September 2003) Arecent World Health Organization report states
More informationNutrition Basics. Chapter McGraw-Hill Higher Education. All rights reserved.
Nutrition Basics Chapter 12 1 The Body s Nutritional Requirements Essential nutrients The Six Essential Nutrients: Proteins, Fats, Carbohydrates, Vitamins, Minerals, Water Defined as : Nutrients one must
More informationCholesterol Levels -- What They Mean, Diet and Treatment
Cholesterol Levels -- What They Mean, Diet and Treatment What Is Cholesterol? We may associate cholesterol with fatty foods, but most of the waxy substance is made by our own bodies. The liver produces
More informationLipids Types, Food Sources, Functions
Lipids Types, Food Sources, Functions What Are Lipids? Lipids Diverse group of molecules that are insoluble in water Fats The lipid content of diets and foods 1 Lipids in Body Cells and Tissues Types of
More informationTopic: Chronic Heart Failure Cases for Monday s March 21th lecture.
1 Phar6122: CV section Date: 3/10/05 Topic: Chronic Heart Failure Cases for Monday s March 21th lecture. Directions: This handout includes three chronic heart failure cases of increasing difficulty. In
More informationAF in the ER: Common Scenarios CASE 1. Fast facts. Diagnosis. Management
AF in the ER: Common Scenarios Atrial fibrillation is a common problem with a wide spectrum of presentations. Below are five common emergency room scenarios and the management strategies for each. Evan
More informationMNT in a Patient with Diabetes Status Post Myocardial Infarction. MEGAN SOLLOWAY University of Maryland Dietetic Intern March 31, 2015
MNT in a Patient with Diabetes Status Post Myocardial Infarction MEGAN SOLLOWAY University of Maryland Dietetic Intern March 31, 2015 ST-elevated Myocardial Infarction (STEMI) Blood clot blocks blood flow
More informationADHD and Adverse Health Outcomes in Adults
Thomas J. Spencer, MD This work was supported in part by a research grant from Shire (Dr. Spencer) and by the Pediatric Psychopharmacology Council Fund. Disclosures Dr. Spencer receives research support
More informationModule 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension
Module 2 Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension 1 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,
More information13/09/2012. Dietary fatty acids. Triglyceride. Phospholipids:
CARDIOVASCULAR DISEASES (CVD) and NUTRITION Major cause of morbidity & mortality in Canada & other developed countries e.g., majority of approved health claims on food labels relate to lowering CVD Relation
More informationEstablished Risk Factors for Coronary Heart Disease (CHD)
Getting Patients to Make Small Lifestyle Changes That Result in SIGNIFICANT Improvements in Health - Prevention of Diabetes and Obesity for Better Health Maureen E. Mays, MD, MS, FACC Director ~ Portland
More informationLipid Management: A Case-Based Approach. Overview. Simple Lipid Therapy Approach. Patients have lipid disorders of:
Lipid Management: A Case-Based Approach Patrick E. McBride, M.D., M.P.H. Professor of Medicine, Cardiovascular Medicine Associate Director, Preventive Cardiology Program UW School of Medicine and Public
More informationMedications for Type 2 Diabetes CDE Exam Preparation. Wendy Graham, RD, CDE Mentor, WWD Angela Puim, RPh, CDE, CRE Preston Medical Pharmacy
Medications for Type 2 Diabetes CDE Exam Preparation Wendy Graham, RD, CDE Mentor, WWD Angela Puim, RPh, CDE, CRE Preston Medical Pharmacy Competency for CDE Exam 3.1.A Oral Medications for Type 2 Diabetes
More informationUTHEALTH HOUSTON CCTS BIOBANK VARIABLE LIST
Please check the requested variables:, and/or. Obtained at Initial Hospital Recruitment Demographics: Age Gender Marital Status Ethnicity Race Height (inches) Weight (pounds) Main language spoken Socioeconomic
More information(For National Authority Use Only) Name of Study Drug: to Part of Dossier:
2.0 Synopsis Abbott Laboratories Individual Study Table Referring to Part of Dossier: (For National Authority Use Only) Name of Study Drug: Volume: ABT-335 Name of Active Ingredient: Page: ABT-335, A-7770335.115
More informationCARDIOVASCULAR FITNESS CENTER COMMUNITY PROGRAM
CARDIOVASCULAR FITNESS CENTER COMMUNITY PROGRAM The Community Exercise Program (located on the 1st floor of Mountainside Medical Center) is a medically supervised program for individuals who wish to learn
More informationApplication of the Diabetes Algorithm to a Patient
Application of the Diabetes Algorithm to a Patient Apply knowledge gained from this activity to improve disease management and outcomes for patients with T2DM and obesity Note: The cases in this deck represent
More informationKnow Your Numbers Blood Pressure Cholesterol Blood Sugar
Know Your Numbers Blood Pressure Cholesterol Blood Sugar 2015 Wellness Warriors Sponsored by: Wayne State University Presented by: Debbie Cavender, RDN STRATEGIC WELLNESS, LLC The information in this presentation
More informationDIET 10-DAY DETOX STARTER KIT MARK HYMAN, MD CHOLESTEROL SOLUTION. Author of the bestsellers The 10-Day Detox Diet and The Blood Sugar Solution
THE BLOOD SUGAR SOLUTION 10-DAY DETOX DIET STARTER KIT CHOLESTEROL SOLUTION MARK HYMAN, MD Author of the bestsellers The 10-Day Detox Diet and The Blood Sugar Solution 2 Simply put, food can cause disease,
More informationUpdate On Diabetic Dyslipidemia: Who Should Be Treated With A Fibrate After ACCORD-LIPID?
Update On Diabetic Dyslipidemia: Who Should Be Treated With A Fibrate After ACCORD-LIPID? Karen Aspry, MD, MS, ABCL, FACC Assistant Clinical Professor of Medicine Warren Alpert Medical School of Brown
More informationYour cholesterol levels. Questions or concerns
Because you have high cholesterol you should: Know your cholesterol levels Take the medicine to lower cholesterol that your doctor has told you to take Follow your doctor s treatment plan Keep your appointments
More informationNatural Approaches to Cholesterol Deregulation
Most of us have inherited certain physiological weaknesses that may require ongoing attention and as we get older certain issues tend to arise that need specific requirements. Cholesterol Imbalance and
More informationAtheroRegression Clinic (ARC) Protocols
AtheroRegression Clinic (ARC) Protocols Dmitri Vasin, M.D. Drew Garcia, PA C ARC Goals of Therapy Targets are intentionally simplified and reduced to a bare minimum to keep patients and providers on the
More informationDisclosures. Overview 9/30/ ACC/AHA Guidelines on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 ACC/AHA Guidelines on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults 2014 AAHP Fall Seminar Sherry Myatt, PharmD, BCPS Assistant Director of Pharmacy for
More informationHeart Disease and Prevention PRESENTED BY: DOTTIE CRAIG NP- C, JANE ARCHER NP-C, KATHY DAPPER RN, NICCI FRAVEL RN
Heart Disease and Prevention PRESENTED BY: DOTTIE CRAIG NP- C, JANE ARCHER NP-C, KATHY DAPPER RN, NICCI FRAVEL RN Objectives Identify Normal Systolic and Diastolic Blood pressures Recognize common Antihypertensive
More informationTopic: Chronic Heart Failure Cases for Monday s March 21th lecture.
1 Phar6122: CV section Date: 3/21/05 Topic: Chronic Heart Failure Cases for Monday s March 21th lecture. Directions: This handout includes three chronic heart failure cases of increasing difficulty. In
More informationCardiac Pathophysiology
Cardiac Pathophysiology Evaluation Components Medical history Physical examination Routine laboratory tests Optional tests Medical History Duration and classification of hypertension. Patient history of
More informationCardiovascular Complications of Diabetes
VBWG Cardiovascular Complications of Diabetes Nicola Abate, M.D., F.N.L.A. Professor and Chief Division of Endocrinology and Metabolism The University of Texas Medical Branch Galveston, Texas Coronary
More informationCHOLESTEROL CONTENT CREATED BY. Learn more at
CHOLESTEROL CONTENT CREATED BY Learn more at www.health.harvard.edu TALK WITH YOUR DOCTOR Table of Contents what is cholesterol? 4 Whether this is your first visit or a follow-up, asking your doctor these
More informationTo Do or Not To Do? The Annual Physical- Beyond The PAP And Breast Exam
1/27/2015 To Do or Not To Do? The Annual Physical- Beyond The PAP And Breast Exam Fleur Sack, M.D., FAAFP Society of General Internal Medicine Cochrane review of 182,000 people followed for 9 years : the
More informationWHOLE HEALTH: CHANGE THE CONVERSATION. Lipids Summary Clinical Tool
Advancing Skills in the Delivery of Personalized, Proactive, Patient-Driven Care Lipids Summary Clinical Tool This document has been written for clinicians. The content was developed by the Integrative
More informationThe Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk
The Metabolic Syndrome Update 2018 Marc Cornier, M.D. Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine
More informationClinical Cases in Diabetes Management. Joseph Cook D.O.
Clinical Cases in Diabetes Management Joseph Cook D.O. Objectives State the prevalence of Diabetes Mellitus in Ohio State the percentage of diabetic patients in the U.S. treated by Primary Care Physicians
More informationUnderstanding Cholesterol and Triglycerides
MINTO PREVENTION & REHABILITATION CENTRE CENTRE DE PREVENTION ET DE READAPTATION MINTO Understanding Cholesterol and Triglycerides About This Kit Along with cigarette smoking, high blood pressure, physical
More informationHeart Attack. PART 2. Health Issues of Special Interest to Women. Heart and Artery Diseases. Chapter 4
PART 2. Health Issues of Special Interest to Women Heart Attack Heart and Artery Diseases Chapter 4 You may not know that diseases of the heart and arteries (primarily heart attack, heart disease, high
More informationInformation in these slides is used with permission from St. Mary s Cardiac Rehab
Information in these slides is used with permission from St. Mary s Cardiac Rehab Prescription Pointers Heart Medications Questions!! 2-4% of patients who visit ER s have experienced a medication misadventure
More informationMetabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology
Metabolic Syndrome Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Disclosure No conflict of interest No financial disclosure Does This Patient Have Metabolic Syndrome? 1. Yes 2. No Does This Patient
More informationArteriosclerosis & Atherosclerosis
Arteriosclerosis & Atherosclerosis Arteriosclerosis = hardening of arteries = arterial wall thickening + loss of elasticity 3 types: -Arteriolosclerosis -Monckeberg medial sclerosis -Atherosclerosis Arteriosclerosis,
More informationCase # 278 Should lipoprotein cholesterol assays disappear?
Case # 278 Should lipoprotein cholesterol assays disappear? Let's get into the case: I was contacted by a provider who states: "I have a 70 year old guy with absolutely no cardiac risk factors except for
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Caduet) Reference Number: CP.CPA.237 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Medicaid Medi-Cal Revision Log See Important Reminder at the end of this policy
More informationGender: M Chart No: Fasting: Yes. Boston Heart HDL Map TM Test 1 ApoA-I (mg/dl) levels in HDL particles. α Range > <14 mg/dl. α-2 50.
Pro vider: Ordering Provider 123 Main Street Anytown, ST 12345 Account No: DOB: 00/00/1950 Framingham Risk Score: Patient Info: FAMILY HIST CVD Lipid, Lipoprotein and Apolipoprotein Tests Total Cholesterol
More informationTest5, Here is Your My5 to Health Profile with Metabolic Syndrome Insight
Test5, Here is Your My5 to Health Profile with Metabolic Syndrome Insight Quest, Quest Diagnostics, the associated logo, and all associated Quest Diagnostics marks are the registered trademarks of Quest
More informationLipids: Translating Studies into Practice. WD04: Cortney Joneikis, MD, MS Bob Gleeson, MD Jeff Whittle, MD, MPH
Lipids: Translating Studies into Practice WD04: Cortney Joneikis, MD, MS Bob Gleeson, MD Jeff Whittle, MD, MPH Discussants: Bob Gleeson, MD Assistant Professor of Medicine, General Internal Medicine Medical
More informationThe Latest Generation of Clinical
The Latest Generation of Clinical Guidelines: HTN and HLD Dave Brackett Clinical Guideline Purpose Uniform approach Awareness of key details Diagnosis Treatment Monitoring Evidence based approach Inform
More informationYour Guide to Lowering Heart Disease and Stroke Risk
Your Guide to Lowering Heart Disease and Stroke Risk An Introduction to Berkeley HeartLab s Test Results Bunny Foxhoven, RD, CE 303-973-6132 Susan Buckley, RD South Denver Cardiology Plaque Formation Family
More informationNutrition & Wellness for Life 2012 Chapter 6: Fats: A Concentrated Energy Source
Tools: Printer 8.5 x 11 paper Scissors Directions: 1. Print 2. Fold paper in half vertically 3. Cut along dashed lines Copyright Goodheart-Willcox Co., Inc. All rights reserved. Tissue in which the body
More informationHypertension Pharmacotherapy: A Practical Approach
Hypertension Pharmacotherapy: A Practical Approach Ronald Victor, MD Burns & Allen Chair in Cardiology Director, The Hypertension Center Associate Director, The Heart Institute Hypertension Center 1. 2.
More informationBe Still My Beating Heart!
030-Coronary Disease 1/13/04 12:21 PM Page 30 Be Still My Beating Heart! An Update on Coronary Disease Heart disease has long been considered a male health problem, because men are affected at an earlier
More informationA N A C P S P E C I A L R E P O R T. Understanding and Managing Your. Triglycerides
A N A C P S P E C I A L R E P O R T Understanding and Managing Your Triglycerides What are Triglycerides? Triglycerides are one of several types of fat in your body, and the most common of them all. Along
More informationHeart disease in Women
Heart disease in Women Extent and risk assessment Charles McCreery MB FACC St Vincent's Hospital Dublin St Columcille s Hospital Dublin Natural Progression of Atherosclerosis Heart disease risk differs
More informationLong-Term Complications of Diabetes Mellitus Macrovascular Complication
Long-Term Complications of Diabetes Mellitus Macrovascular Complication Sung Hee Choi MD, PhD Professor, Seoul National University College of Medicine, SNUBH, Bundang Hospital Diabetes = CVD equivalent
More informationCurrent Treatment Of Ischemic Heart Disease In the United States: An Overview. By Dr Gary Mo
Current Treatment Of Ischemic Heart Disease In the United States: An Overview By Dr Gary Mo 1 Ischemic Heart Disease in the US 1. Cardiovascular disease remains the most common cause of death and is responsible
More informationBlood Pressure Measurement (children> 3 yrs)
Blood Pressure Measurement (children> 3 yrs) If initial BP elevated, repeat BP manually 2x and average, then classify Normal BP Systolic and diastolic
More information1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones?
1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones? 3How are dietary lipids transported? 4How lipids synthesized in the liver are transported? 5 Lipoprotien
More informationCholesterol (blood, plasma, serum)
1 Cholesterol (blood, plasma, serum) 1 Name and description of analyte 1.1 Name of analyte Cholesterol (plasma; also blood, serum) 1.2 Alternative names 2,15-dimethyl-14-(1,5-dimethylhexyl)tetracyclo[8.7.0.0
More informationLipids, pt. 1. Feb. 3, Bio 28: Nutrition Instructor: Paul Nagami Laney College
Lipids, pt. 1 Feb. 3, 2014 Bio 28: Nutrition Instructor: Paul Nagami Laney College Today s Agenda Reminders + Administrative Details What Are Lipids? Chemistry and Types of Lipids Fatty Acids Saturated
More informationConflicts of interest. What's the Skinny on the Lipid Guidelines? Key Differences. Are you applying the new ACC/AHA Lipid guidelines in your practice?
Conflicts of interest What's the Skinny on the Lipid Guidelines? The presenter has no relevant conflicts of interest to disclose. Kathleen Vest, PharmD, CDE, BCACP At the end of this presentation, pharmacist
More informationProducing Peak. Performance. regain your edge TheJoeDillonDifference.com
Producing Peak Performance regain your edge 310-740-2473 TheJoeDillonDifference.com improved blood panel Less or no Rx drugs More energy Less body fat / more muscle Sounder sleep Sharper memory Healthier
More informationNutrition, Food, and Fitness. Chapter 6 Fats: A Concentrated Energy Source
Nutrition, Food, and Fitness Chapter 6 Fats: A Concentrated Energy Source Tools: Printer (color optional) 4 sheets of 8.5 x 11 paper Scissors Directions: 1. Print 2. Fold paper in half vertically 3. Cut
More informationSevere Hypertension. Pre-referral considerations: 1. BP of arm and Leg 2. Ambulatory BP 3. Renal causes
Severe Hypertension *Prior to making a referral, call office or Doc Halo, to speak with a Cardiologist or APP to discuss patient and possible treatment options. Please only contact the patient's cardiologist.
More information4/14/2018 DYSLIPIDEMIA CASES. Mary Malloy, MD. I have nothing to disclose
DYSLIPIDEMIA CASES Mary Malloy, MD I have nothing to disclose 1 Case 1 A 24 year old healthy, slender woman is referred because she has a family history of premature CAD (mother, age 59, had onset of angina
More informationDiabetes and the Heart
Diabetes and the Heart Jeffrey Boord, MD, MPH Advances in Cardiovascular Medicine Kingston, Jamaica December 6, 2012 Outline Screening for diabetes in patients with CAD Screening for CAD in patients with
More informationPharmacology Challenges: Managing Statin Myalgia
Clinical Case: RM is a 50 year-old African American woman with a past medical history of type diabetes, dyslipidemia, hypertension and peripheral arterial disease. She had been prescribed simvastatin 80
More information